Literature DB >> 28757399

Diabetic retinopathy, an overview.

M Elizabeth Hartnett1, Wolfgang Baehr2, Yun Z Le3.   

Abstract

This overview introduces contributions to a special issue on causes of vision loss from diabetes mellitus, focusing on the retina and also the cornea. Diabetic retinopathy is the most common and leading cause of vision loss among people with diabetes. Research to detect early symptoms, understand mechanisms leading to diabetic eye disease, and the development of treatments is a highly active research area, with currently about 2000 scientific publication per year. We provide a series of 27 comprehensive reviews and research articles from leading experts in the field.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28757399     DOI： 10.1016/j.visres.2017.07.006

Source DB:  PubMed          Journal:  Vision Res        ISSN： 0042-6989            Impact factor:   1.886


  14 in total

1.  Within-subject assessment of foveal avascular zone enlargement in different stages of diabetic retinopathy using en face OCT reflectance and OCT angiography.

Authors:  Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui
Journal:  Biomed Opt Express       Date:  2018-11-05       Impact factor: 3.732

2.  miR‑133b regulates proliferation and apoptosis in high‑glucose‑induced human retinal endothelial cells by targeting ras homolog family member A.

Authors:  Jun Yao; Jihong Wang; Yong Yao; Kelei Wang; Qianqian Zhou; Ying Tang
Journal:  Int J Mol Med       Date:  2018-05-18       Impact factor: 4.101

3.  NONCONFOCAL ULTRA-WIDEFIELD SCANNING LASER OPHTHALMOSCOPY: Polarization Artifacts and Diabetic Macular Edema.

Authors:  Radwan S Ajlan; Luke R Barnard; Martin A Mainster
Journal:  Retina       Date:  2020-07       Impact factor: 3.975

4.  The findings of corneal specular microscopy in patients with type-2 diabetes mellitus.

Authors:  Nurdan Gamze Taşlı; Erel Icel; Yücel Karakurt; Turgay Ucak; Adem Ugurlu; Hayati Yilmaz; Emin Murat Akbas
Journal:  BMC Ophthalmol       Date:  2020-06-03       Impact factor: 2.209

5.  Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.

Authors:  Aaron B Simmons; Colin A Bretz; Haibo Wang; Eric Kunz; Kassem Hajj; Carson Kennedy; Zhihong Yang; Thipparat Suwanmanee; Tal Kafri; M Elizabeth Hartnett
Journal:  Angiogenesis       Date:  2018-05-05       Impact factor: 9.596

6.  Fushiming Capsule Attenuates Diabetic Rat Retina Damage via Antioxidation and Anti-Inflammation.

Authors:  Mengshan He; Pan Long; Lunfeng Guo; Mingke Zhang; Siwang Wang; Hongling He
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-18       Impact factor: 2.629

7.  Intravitreal injection of adenosine A2A receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice.

Authors:  Inês Dinis Aires; Maria Helena Madeira; Raquel Boia; Ana Catarina Rodrigues-Neves; Joana Margarida Martins; António Francisco Ambrósio; Ana Raquel Santiago
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

Review 8.  Eyeing the Extracellular Matrix in Vascular Development and Microvascular Diseases and Bridging the Divide between Vascular Mechanics and Function.

Authors:  Brahim Chaqour; Charles Karrasch
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

9.  Arctiin attenuates high glucose-induced human retinal capillary endothelial cell proliferation by regulating ROCK1/PTEN/PI3K/Akt/VEGF pathway in vitro.

Authors:  Min Zhou; Guobing Li; Liancai Zhu; Huyue Zhou; Laichun Lu
Journal:  J Cell Mol Med       Date:  2020-04-16       Impact factor: 5.310

Review 10.  Do Genomic Factors Play a Role in Diabetic Retinopathy?

Authors:  Andrea P Cabrera; Finny Monickaraj; Sampathkumar Rangasamy; Sam Hobbs; Paul McGuire; Arup Das
Journal:  J Clin Med       Date:  2020-01-14       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.